Company History - Aarti Drugs
Aarti Drugs Limited was incorporated on 28th September, 1984 as a
Private Limited Company. It was converted into a Public Limited
Company on 1st July, 1992.
The Company is presently engaged in the manufacture of MNI(300 TPA),
MTZ (96 TPA), TNZ (84 TPA), DMZ (90 TPA) and Isoniazid (INH) (96
TPA). The Company started its commercial production is March 1987
at G.I.D.C. Industrial Estate, Sarigam, Dist. Valsad, Gujarat. This
project was put up with financial assistance from Gujarat State
Finance Corporation (GSFC) and Gujarat Industrial Investment
The Company now proposes to expand the capacities for the above
products, except INH and also proposes to set up a new plant for the
manufacture of Glyoxal and Ammonium Sulphate. The Company has been
consistently making profits and has maintained an unbroken dividend
record since the year 1990-91.
The Company is a part of the Alchemie Group of Companies. The
Company is promoted by Mr. Chandrakant V.Gogri, Mr.Rajendra V.Gogri
and Mr. Shantilal T. Shah. Mr. P.M. Patil and Mr. S. P. Nachane
joined the Group in 1981. The Alchemie Group is a professionally
managed, multi-product, multilocation Group comprising 24
manufacturing units with a total turnover of over Rs.100
crores for the year 1991-92. The products of the Group, exceeding 40,
range from industrial chemicals and dye intermediates to bulk drugs
and fine chemicals. The Group's customer list includes most of the
leading chemical companies in the country. The Group's turnover and
profits have increased five-fold in the last 5 years. It also
recorded an export turnover of more than Rs. 30 crores in the year
1991-92. The Group units export products mainly to the general
currency areas such as USA, UK, Switzerland and Germany.
2000 - The Company proposed to acquire 15,31,000 No. of equity shares
Alchemie Organics Ltd 33.44 per cent of the total paid-up
capital of AOL
held by the other promoters.
2002-Gauri Balankhe appointed as Compliance Officer of Aarti Drugs.
-Aarti Drugs Ltd. has informed that the Company has changed its
Registrar and Share Transfer Agent and Depository interface for
Handling Depository related operations by appointing M/s Sharepro
Services in place of M/s R & D Consultants Ltd w.e.f. January 16,
2004 subject to completion of necessary formalities as maybe
prescribed in this regard. The address and telephone number of M/s
Sharepro Services for all investors related services are as under: 1.
M/s Sharepro Services, Unit : Aarti Drugs Ltd; 912, Raheja Centre,
Free Press Journal Road, Nariman Point, Mumbai 400 021, Tel nos :
22881569, 22884527. 2. M/s Sharepro Services, Unit : Aarti Drugs Ltd;
912, Satam Estate, 3rd Floor, Above Bank of Baroda, Chakla, Andheri
(East), Mumbai 400 099, Tel nos : 28215168, 28319828; Fax nos :
-Aarti bags European certification for three drugs
-Delist from Ahmedabad Stock Exchange (ASE) with effect from October
-Aarti Drugs enters into JV with API Manufacturing Chinese Company
- Aarti Drugs Ltd. has informed that Mr. Prakash Khedekar, Company
Secretary & Compliance Officer of the Company has resigned from the
position of Company Secretary & Compliance Officer with effect from
October 31, 2006. Further, Mrs. Mona Patel, possessing requisite
qualifications, has been appointed as Company Secretary & Compliance
Officer of the Company with effect from November 01, 2006.
- Aarti Drugs Ltd has has appointed Shri Krishnacharya Govindacharya
Akamanchi & Prof. Sudhir Prakash B. Sawant as Independent Directors
of the Company.
-Aarti Drugs has recommended dividend of Rs. 5/- (50%) per share
-Mr. Sunny D. Pagare, has been appointed as Company Secretary &
Compliance Officer of the Company
-Aarti Drugs has recommended Final Dividend of Rs. 2.5 /-per share
-Mr. Adhish P. Patil, has been appointed as Chief Financial Officer
of the Company
-Aarti Drugs has declared Final dividend Rs. 3.00 (30%) per share
-Aarti Drugs has recommended a Final Dividend of Rs. 4/- per share on
Equity Shares of Rs. 10/- each.
-Aarti Drugs has commenced the new R&D center at MIDC Tarapur.
-Aarti Drugs has recommended a Final dividend @ Rs. 5.50 ps. (55%)
-Aarti Drugs Ltd has will participate at 'Centrum Pharma Day'
-The Company has allotted the Bonus Shares to its shareholders in the
Ratio of 1:1.